datetime,headline,summary,related,lang,source
2020-11-27 09:24:59-05:00,"Global Neural Pain Treatment Market 2020-2027:Emerging Opportunities, Revenue Analysis and Growth Projections by GlaxoSmithKline PLC., Novartis AG, Zydus Cadila, Dr. Reddy's Laboratories Ltd, Amneal Pharmaceuticals LLC, Fresenius SE & Co. KGaA","According to the latest report published by Data Bridge Market Research, the Neural Pain Treatment Market is anticipated to grow at a steady pace over the forecast period 2020 – 2027. The report sheds light on the various trends and",AMRX,en,OpenPR
2020-11-24 07:28:55-05:00,"Hydroxychloroquine Market - Sanofi S.A., Amneal Pharmaceuticals, Inc., Laurus Labs Limited, Zydus Pharmaceuticals, Inc., Prasco Laboratories, Dr. Reddy's Laboratories, Cadila Pharmaceuticals Novartis International AG",An informative study on the Hydroxychloroquine Market from 2020-2027 has lately released for the database of Coherent Market Insights that helps by making business conclusions and shape the future of the organizations. Individual analysis of top regions and countries like,AMRX,en,OpenPR
2020-11-09 02:30:36-05:00,"U.S. HSV1 Treatment Market 2020:Size,Incredible Possibilities And Growth Analysis By Teva Pharmaceuticals USA, Inc. (A Subsidiary of Teva Pharmaceutical Industries Ltd.), Avet Pharmaceuticals Inc., Amneal Pharmaceuticals LLC., Tolmar Pharmaceuticals",HSV1 treatment market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 11.9% in the forecast period of 2020 to 2027,AMRX,en,OpenPR
2020-05-15 11:00:08-05:00,Amneal (AMRX) Moves to Buy: Rationale Behind the Upgrade,"Amneal (AMRX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.",AMRX,en,Zacks Investment Research
2020-05-11 10:35:02-05:00,Amneal Pharmaceuticals (AMRX) Surpasses Q1 Earnings and Revenue Estimates,"Amneal (AMRX) delivered earnings and revenue surprises of 150.00% and 12.50%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?",AMRX,en,Zacks Investment Research
2020-05-08 07:53:00-05:00,Is a Surprise Coming for Amneal (AMRX) This Earnings Season?,Amneal (AMRX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.,AMRX,en,Zacks Investment Research
2020-01-16 03:35:00-05:00,Should Value Investors Pick Amneal Pharma (AMRX) Stock Now?,Let's see if Amneal Pharmaceuticals (AMRX) stock is a good choice for value-oriented investors right now from multiple angles.,AMRX,en,Zacks Investment Research
2019-12-12 12:01:20-05:00,Here’s Why Amneal Pharmaceuticals (AMRX) Stock Skyrocketed 50% Today,"As the saying goes, good things come to those who wait, and following a year of decline, patience might finally be paying off … The post Here’s Why Amneal Pharmaceuticals (AMRX) Stock Skyrocketed 50% Today appeared first on Smarter Analyst .",AMRX,en,Smarter Analyst
2019-11-12 10:47:09-05:00,"Teva Vs. Amneal: JPMorgan Sees Hope For One, Decline For The Other","It’s been a rough 2019 for some biotechs. Amneal Pharmaceuticals Inc (NYSE: AMRX ) is down 81% year-to-date, while Teva Pharmaceutical Industries Ltd (NYSE: TEVA ) is down 41%. JPMorgan sees redemption in one of the stocks — and further decline in the other. The Analyst Chris Schott upgraded Teva from Underweight to Neutral with an $8 price target and downgraded Amneal from Neutral to Underweight. The Teva Thesis With positive optics on Teva’s opioid exposure and stabilizing mid-term fundamentals, JPMorgan sees balance in the stock’s costs and benefits. “We remain fairly bearish on the longer-term setup for the company between its lack of growth-drivers (Ajovy underperforming expectations so far, lingering LOEs, etc.) and still high-leverage (especially after taking into account potential … Full story available on Benzinga.com",AMRX,en,Benzinga Feeds
2019-11-12 09:24:01-05:00,Amneal Pharmaceuticals (NYSE:AMRX) Downgraded to “Underweight” at JPMorgan Chase & Co.,"Amneal Pharmaceuticals (NYSE:AMRX) was downgraded by JPMorgan Chase & Co. from a “neutral” rating to an “underweight” rating in a report released on Tuesday, The Fly reports. Several other research firms have also issued reports on AMRX. SunTrust Banks reissued a “buy” rating and issued a $5.00 target price on shares of Amneal Pharmaceuticals in […]",AMRX,en,Modern Readers
2019-11-07 23:44:41-05:00,"Amneal Pharmaceuticals (NYSE:AMRX) Posts Earnings Results, Misses Expectations By $0.09 EPS","Amneal Pharmaceuticals (NYSE:AMRX) released its earnings results on Wednesday. The company reported $0.04 EPS for the quarter, missing the Zacks’ consensus estimate of $0.13 by ($0.09), Briefing.com reports. The business had revenue of $378.30 million for the quarter, compared to the consensus estimate of $403.90 million. Amneal Pharmaceuticals had a positive return on equity of […]",AMRX,en,Modern Readers
2019-10-30 09:34:02-05:00,Earnings Preview: Amneal Pharmaceuticals (AMRX) Q3 Earnings Expected to Decline,Amneal (AMRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,AMRX,en,Zacks Investment Research
2019-08-16 06:33:27-05:00,"The Daily Biotech Pulse: Roche Snags Double Nod For Personalized Cancer Drug, Bellicum Offering, Nabriva Braces For Contepo Resubmission","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 15) Novocure Ltd (NASDAQ: NVCR ) Down In The Dumps (Biotech stocks hitting 52-week lows on Aug. 15) AbbVie Inc (NYSE: ABBV ) Acer Therapeutics Inc (NASDAQ: ACER ) Adaptimmune Therapeutics PLC – ADR (NASDAQ: ADAP ) Aerpio Pharmaceuticals Inc (NASDAQ: ARPO ) Aldeyra Therapeutics Inc (NASDAQ: ALDX ) Amneal Pharmaceuticals Inc (NYSE: AMRX ) Alector Inc (NASDAQ: ALEC ) ANCHIANO THERAP/S ADR (NASDAQ: ANCN ) Bellicum Pharmaceuticals Inc (NASDAQ: BLCM ) BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX ) BioTelemetry Inc (NASDAQ: BEAT ) Cellectis SA (NASDAQ: CLLS ) Cyclerion Therapeutics Inc (NASDAQ: CYCN ) DelMar Pharmaceuticals Inc (NASDAQ: DMPI )(announced pricing of its $6.5 million common stock offering at $1 per share) Eton Pharmaceuticals Inc (NASDAQ: ETON ) Fulcrum Therapeutics Inc (NASDAQ: FULC ) Gemphire Therapeutics Inc (NASDAQ: GEMP ) Genetic Technologies Limited (NASDAQ: GENE ) GENFIT S A/ADR (NASDAQ: GNFT ) HTG Molecular Diagnostics Inc (NASDAQ: HTGM ) Idera Pharmaceuticals Inc (NASDAQ: IDRA ) Innovate Biopharmaceuticals Inc (NASDAQ: INNT ) Ironwood Pharmaceuticals, Inc.",AMRX,en,Benzinga
2019-08-15 06:45:19-05:00,"The Daily Biotech Pulse: Mallinkckrodt's Terlipressin, Deciphera Offering, Sellas Reboots On Earnings","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 14) GENMAB A/S/S ADR (NASDAQ: GMAB ) (announced first-half results and raised 2019 guidance) Down In The Dumps (Biotech stocks hitting 52-week lows on Aug. 14) Acer Therapeutics Inc (NASDAQ: ACER ) (reacted to second-quarter results) Acorda Therapeutics Inc (NASDAQ: ACOR ) Adaptimmune Therapeutics PLC – ADR (NASDAQ: ADAP ) Akorn, Inc. (NASDAQ: AKRX ) Amneal Pharmaceuticals Inc (NYSE: AMRX ) aTyr Pharma Inc (NASDAQ: LIFE ) (reacted to second-quarter results) Bicycle Therapeutics PLC (NASDAQ: BCYC ) BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) Cancer Genetics Inc (NASDAQ: CGIX ) Cellectis SA (NASDAQ: CLLS ) DelMar Pharmaceuticals Inc (NASDAQ: DMPI )(announced $6.5 million common stock offering) DiaMedica Therapeutics Inc (NASDAQ: DMAC )(reacted to second-quarter results) Ekso Bionics Holdings Inc (NASDAQ: EKSO ) Fulcrum Therapeutics Inc (NASDAQ: FULC ) GENFIT S A/ADR (NASDAQ: GNFT ) Kiniksa Pharmaceuticals Ltd (NASDAQ: KNSA ) Medigus ADR (NASDAQ: MDGS ) Meridian Bioscience, Inc.",AMRX,en,Benzinga
2019-08-06 06:22:08-05:00,"The Daily Biotech Pulse: Sanofi's Dupixent Found Effective For Pediatric Itchy Skin, Novavax Gets Nod For Late-Stage Study, Allakos Offering",Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks No biotech stocks hit 52-week highs Monday. Down In The Dumps (Biotech stocks hitting 52-week lows on Aug. 5) Acer Therapeutics Inc (NASDAQ: ACER ) Aclaris Therapeutics Inc (NASDAQ: ACRS ) Actinium Pharmaceuticals Inc (NYSE: ATNM ) Adaptimmune Therapeutics PLC – ADR (NASDAQ: ADAP ) Adaptive Biotechnologies Corp (NASDAQ: ADPT ) Agios Pharmaceuticals Inc (NASDAQ: AGIO ) Akcea Therapeutics Inc (NASDAQ: AKCA )(announced its subsidiary Keryx Biopharmaceuticals has reached a settlement agreement with Endo International PLC (NASDAQ: ENDP )'s Par Pharam related to Auryxia) Akebia Therapeutics Inc (NASDAQ: AKBA ) Alder Biopharmaceuticals Inc (NASDAQ: ALDR ) Amneal Pharmaceuticals Inc (NYSE: AMRX )( reported below-consensus Q2 results and cut its 2019 guidance) AnaptysBio Inc (NASDAQ: ANAB ) Arcus Biosciences Inc (NYSE: RCUS ) Assertio Therapeutics Inc (NASDAQ: ASRT ) Atara Biotherapeutics Inc (NASDAQ: ATRA ) Bellicum Pharmaceuticals Inc (NASDAQ: BLCM ) Atreca Inc (NASDAQ: BCEL ) Cellectis SA (NASDAQ: CLLS ) Champions Oncology Inc (NASDAQ: CSBR ) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) Crinetics Pharmaceuticals Inc (NASDAQ: CRNX ) Cyclerion Therapeutics Inc (NASDAQ: CYCN ) Eloxx Pharmaceuticals Inc (NASDAQ: ELOX )(commenced Phase 2 study of ELX-02 in cystinosis) Endo International Enochian Biosciences Inc (NASDAQ: ENOB ) ESSA Pharma Inc (NASDAQ: EPIX ) Galmed Pharmaceuticals Ltd (NASDAQ: GLMD )(reacted to Q2 results) GENFIT S A/ADR (NASDAQ: GNFT ) GlycoMimetics Inc (NASDAQ: GLYC )(reported that Phase 3 trial evaluating sickle cell disease drug it is co-developing with Pfizer Inc.,"ANAB,AMRX",en,Benzinga
2019-08-05 11:15:02-05:00,Amneal Pharmaceuticals (AMRX) Q2 Earnings and Revenues Lag Estimates,"Amneal (AMRX) delivered earnings and revenue surprises of -40.00% and -6.21%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?",AMRX,en,Zacks Investment Research
2019-08-01 09:33:35-05:00,Analysts Estimate Amneal Pharmaceuticals (AMRX) to Report a Decline in Earnings: What to Look Out for,Amneal (AMRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,AMRX,en,Zacks Investment Research
2019-07-15 09:35:18-05:00,"Morgan Stanley Downgrades Teva, Endo On Drug Pricing And Litigation Concerns","Pharmaceutical stocks have been under pressure for the past few trading days, but one Wall Street analyst said the worst is yet to come for a handful of specialty drugmakers. The Analyst Morgan Stanley analyst David Risinger made the following changes to his pharma stock coverage: Endo International PLC (NASDAQ: ENDP ) downgraded from Equal-Weight to Underweight, price target lowered from $8 to $3. Teva Pharmaceutical Industries Ltd (NYSE: TEVA ) downgraded from Equal-Weight to Underweight, price target lowered from $16 to $6. Mylan NV (NASDAQ: MYL ) reiterated at Overweight, price target lowered from $32 to $22. Amneal Pharmaceuticals Inc (NYSE: AMRX ) reiterated at Equal-Weight, price target … Full story available on Benzinga.com",AMRX,en,Benzinga
2019-07-12 06:24:17-05:00,"The Daily Biotech Pulse: Hookipa Leaps, Illumina Dims On Q2 Warning, Novartis-Amgen Halt Alzheimer's Study","Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on July 11) Enlivex Therapeutics Ltd (NASDAQ: ENLV ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) Insulet Corporation (NASDAQ: PODD ) Masimo Corporation (NASDAQ: MASI ) Novocure Ltd (NASDAQ: NVCR ) Penumbra Inc (NYSE: PEN ) SAGE Therapeutics Inc (NASDAQ: SAGE ) Down In The Dumps (Biotech stocks hitting 52-week lows on July 11) Aimmune Therapeutics Inc (NASDAQ: AIMT )(fell on a release from the Institute for Clinical and Economic Review, which expressed skepticism about peanut allergy drug vis-à-vis avoiding the food altogether) Amneal Pharmaceuticals Inc (NYSE: AMRX ) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) Intercept Pharmaceuticals Inc (NASDAQ: ICPT ) Iradimed Corp (NASDAQ: IRMD ) See Also: Attention Biotech Investors: Mark Your Calendar For These … Full story available on Benzinga.com",AMRX,en,Benzinga
2019-07-11 15:21:00-05:00,Amneal (AMRX) Down on Guidance Update & Restructuring Plan,Amneal (AMRX) slumps on news of budget cut and reduction in annual guidance.,AMRX,en,Zacks Investment Research
2019-07-11 05:17:30-05:00,"The Daily Biotech Pulse: Neurocrine's Parkinson's Drug Accepted For Review, Sunesis Offering, No Headaches For Biohaven's Migraine Drug","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 10) CONMED Corporation (NASDAQ: CNMD ) Eidos Therapeutics Inc (NASDAQ: EIDX ) Enlivex Therapeutics Ltd (NASDAQ: ENLV ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) Penumbra Inc (NYSE: PEN ) Down In The Dumps (Biotech stocks hitting 52-week lows on July 10) Abeona Therapeutics Inc (NASDAQ: ABEO ) Amneal Pharmaceuticals Inc (NYSE: AMRX ) ( announced a restructuring plan, and also reduced full-year adjusted EBITDA guidance) Atara Biotherapeutics Inc (NASDAQ: ATRA ) Jaguar Health Inc (NASDAQ: JAGX ) VERONA PHARMA P/S ADR (NASDAQ: VRNA ) See Also: Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates Stocks In Focus Neurocrine Says FDA Accepts Regulatory Filing For Parkinson's Drug Neurocrine Biosciences, Inc. (NASDAQ: NBIX ) said the FDA has accepted its NDA for opicapone, a once-daily, oral, selective catechol-O-methyltransferase inhibitor as an adjunctive treatment to levodopa/carbidopa in patients with Parkinson's disease …",AMRX,en,Benzinga
2019-06-13 06:44:09-05:00,"The Daily Biotech Pulse: Savara Slumps On Flunked Trial, NuCana Takes Off, Tetraphase Downsizes","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on June 12) BIOFRONTERA AG/ADR (NASDAQ: BFRA ) BIO-TECHNE Corp (NASDAQ: TECH ) EXACT Sciences Corporation (NASDAQ: EXAS ) Insulet Corporation (NASDAQ: PODD ) Kodiak Sciences Inc (NASDAQ: KOD ) ZIOPHARM Oncology Inc. (NASDAQ: ZIOP ) Down In The Dumps (Biotech stocks hitting 52-week lows on June 12) Acorda Therapeutics Inc (NASDAQ: ACOR ) Amneal Pharmaceuticals Inc (NYSE: AMRX ) ANCHIANO THERAP/S ADR (NASDAQ: ANCN ) Arbutus Biopharma Corp (NASDAQ: ABUS ) Aridis Pharmaceuticals Inc (NASDAQ: ARDS ) BRAINSWAY LTD/S ADR (NASDAQ: BWAY ) Fennec Pharmaceuticals Inc (NASDAQ: FENC ) Innovate Biopharmaceuticals Inc (NASDAQ: INNT ) Melinta Therapeutics Inc (NASDAQ: MLNT ) Minerva Neurosciences Inc (NASDAQ: NERV ) Navidea Biopharmaceuticals Inc (NYSE: NAVB ) NextCure Inc (NASDAQ: NXTC ) Novavax, Inc. (NASDAQ: NVAX ) Novus Therapeutics Inc (NASDAQ: NVUS ) Obseva SA (NASDAQ: OBSV ) RA Medical Systems Inc (NYSE: RMED ) Sellas Life Sciences Group Inc (NASDAQ: SLS ) Sensus Healthcare Inc (NASDAQ: SRTS ) Sierra Oncology Inc (NASDAQ: SRRA ) Unum Therapeutics Inc (NASDAQ: UMRX ) Zomedica Pharmaceuticals Corp (NYSE: ZOM ) Stock In Focus Savara's Pulmonary Disease Drug Does Not Meet Primary Endpoint In Late-stage Study Savara Inc (NASDAQ: SVRA ) said a Phase 3 study dubbed IMPALA that evaluated its …",AMRX,en,Benzinga
2019-05-31 06:34:40-05:00,"The Daily Biotech Pulse: Merrimack To Stay Independent, Chinese Cheer For Beigene, XBiotech Offering","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on May 30) Adverum Biotechnologies Inc (NASDAQ: ADVM ) Misonix, Inc. (NASDAQ: MSON ) Repligen Corporation (NASDAQ: RGEN ) Down In The Dumps (Biotech stocks hitting 52-week lows on May 30) Amneal Pharmaceuticals Inc (NYSE: AMRX ) Abeona Therapeutics Inc (NASDAQ: ABEO ) Acorda Therapeutics Inc (NASDAQ: ACOR ) Advaxis, Inc. (NASDAQ: ADXS ) Alkermes Plc (NASDAQ: ALKS ) Dynavax Technologies Corporation (NASDAQ: DVAX ) Emergent Biosolutions Inc (NYSE: EBS ) Fennec Pharmaceuticals Inc (NASDAQ: FENC ) Insys Therapeutics Inc (NASDAQ: INSY ) Minerva Neurosciences Inc (NASDAQ: NERV ) Mylan NV (NASDAQ: MYL ) Myovant Sciences Ltd (NYSE: MYOV )(announced $100 million worth of common stock offering) Neuronetics Inc (NASDAQ: STIM ) Seres Therapeutics Inc (NASDAQ: MCRB ) Teligent Inc (NASDAQ: TLGT ) Urogen Pharma Ltd (NASDAQ: URGN ) Teva Pharmaceutical Industries Ltd (NYSE: TEVA ) Theravance Biopharma Inc (NASDAQ: TBPH ) Zafgen Inc (NASDAQ: ZFGN ) ( reacted to safety concerns over its diabetes drug following the Type A meeting with FDA) Stock In Focus Merrimack Board Decides Against Sale Following Strategic Review Following the completion of a strategic review, Merrimack Pharmaceuticals Inc (NASDAQ: MACK ) said its board has decided to restructure the company such that its …",AMRX,en,Benzinga
2019-05-21 15:26:47-05:00,"Health Care Sector Update for 05/21/2019: QTNT,ARRY,AMRX,OCUL",Top Health Care StocksTop Health Care Stocks JNJ 0 03 JNJ 0 03 PFE 0 16 PFE 0 16 ABT 0 62 ABT 0 62 MRK 0 83 MRK 0 83 AMGN 0 93 AMGN 0 93 Health care stocks eased slightly just ahead of Tuesday s closing bell with the NYSE Health Care Index rising over 0 7 while shares of,AMRX,en,Nasdaq
2019-05-21 13:07:10-05:00,"Health Care Sector Update for 05/21/2019: ARRY,AMRX,OCUL",Top Health Care StocksTop Health Care Stocks JNJ 0 20 JNJ 0 20 PFE 0 13 PFE 0 13 ABT 0 69 ABT 0 69 MRK 0 74 MRK 0 74 AMGN 0 65 AMGN 0 65 Health care stocks were rising including a nearly 0 8 gain for the NYSE Health Care Index in recent trade Shares of health care companies in,AMRX,en,Nasdaq
2019-05-21 10:04:45-05:00,Arrowhead Pharmaceuticals and Array BioPharma among healthcare gainers; Mallinckrodt and Ocular Therapeutix among losers,No summary available.,AMRX,en,Seeking Alpha
2019-05-17 10:34:43-05:00,Gilead chief defends hefty Truvada price at government hearing,No summary available.,AMRX,en,Seeking Alpha
2019-05-16 06:40:02-05:00,"The Daily Biotech Pulse: FDA Nod For Roche, Trial Results For Agios, Iovance And MacroGenics","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on May 15) Applied Therapeutics Inc (NASDAQ: APLT ) (debuted on Tuesday) Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) Avedro Inc (NASDAQ: AVDR ) Axsome Therapeutics Inc (NASDAQ: AXSM ) MeiraGTx Holdings PLC (NASDAQ: MGTX ) Shockwave Medical Inc (NASDAQ: SWAV ) Silk Road Medical Inc (NASDAQ: SILK ) Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE ) Down In The Dumps (Biotech stocks hitting 52-week lows on May 15) Amneal Pharmaceuticals Inc (NYSE: AMRX ) Auris Medical Holding Ltd (NASDAQ: EARS ) DelMar Pharmaceuticals Inc (NASDAQ: DMPI )(reacted to its third-quarter results) ENDRA Life Sciences Inc (NASDAQ: NDRA )(reacted to its first-quarter results) ImmunoGen, Inc. (NASDAQ: IMGN )(FDA required a new Phase 3 study to be conducted for its ovarian cancer drug) Nuvectra Corp (NASDAQ: NVTR ) Outlook Therapeutics Inc (NASDAQ: OTLK )(reacted to its second quarter results) Teva Pharmaceutical Industries Ltd (NYSE: TEVA ) United Therapeutics Corporation (NASDAQ: UTHR ) Stock In Focus Roche Gets FDA Nod For Leukemia Drug, Reports Positive Results For Solid Tumor Drug Roche Holdings AG Basel ADR (OTC: RHHBY ) said the FDA approved Venclexta in combination with Gazyva for treating people with previously untreated chronic lymphocytic leukemia, or CLL, or small lymphocytic lymphoma, or SLL.",AMRX,en,Benzinga
2019-05-09 15:54:34-05:00,"Amneal Pharmaceuticals, Inc. (AMRX) Q1 2019 Earnings Call Transcript","AMRX earnings call for the period ending March 31, 2019.",AMRX,en,The Motley Fool
2019-05-09 13:56:27-05:00,Amneal Pharmaceuticals' (AMRX) CEO Rob Stewart on Q1 2019 Results - Earnings Call Transcript,"Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Q1 2019 Earnings Conference Call May 09, 2019 8:30 AM ET Company Participants Mark Donohue – Vice President of Investor",AMRX,en,Seeking Alpha
2019-05-09 09:20:15-05:00,Amneal Pharma down 16% on Q1 results,No summary available.,AMRX,en,Seeking Alpha
2019-05-09 09:19:14-05:00,"Amneal Pharmaceuticals, Inc. 2019 Q1 - Results - Earnings Call Slides",No summary available.,AMRX,en,Seeking Alpha
2019-05-09 06:55:06-05:00,Amneal Pharmaceuticals (AMRX) Misses Q1 Earnings Estimates,"Amneal (AMRX) delivered earnings and revenue surprises of -22.22% and 2.66%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?",AMRX,en,Zacks Investment Research
2019-05-09 05:34:37-05:00,"Amneal Pharmaceuticals misses by $0.04, beats on revenue",No summary available.,AMRX,en,Seeking Alpha
2019-05-08 16:30:15-05:00,Amneal Pharmaceuticals Q1 2019 Earnings Preview,No summary available.,AMRX,en,Seeking Alpha
2019-04-16 07:10:46-05:00,"The Daily Biotech Pulse: J&J Earnings, FDA Nod For Mediconova, Proteon To Explore Strategic Alternatives","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on April 15) Amneal Pharmaceuticals Inc (NYSE: AMRX ) Biohaven Pharmaceutical Holding Co Ltd (NYSE: BHVN )(the company is said to explore a potential sale ) Medtronic PLC (NYSE: MDT ) Vermillion, Inc. (NASDAQ: VRML ) Down In The Dumps (Biotech stocks hitting 52-week lows on April 15) Achaogen Inc (NASDAQ: AKAO )(announced bankruptcy filing) Acorda Therapeutics Inc (NASDAQ: ACOR ) Aethlon Medical, Inc. (NASDAQ: AEMD ) Assembly Biosciences Inc (NASDAQ: ASMB )(presented interim mid-stage results of its hepatitis B virus treatment candidate ABI-H0731) CELLECT BIOTECH/S ADR (NASDAQ: APOP ) Conatus Pharmaceuticals Inc (NASDAQ: CNAT )(announced Phase 2 clinical trial evaluating emricasan in NASH patients with cirrhosis and severe portal hypertension) Fennec Pharmaceuticals Inc (NASDAQ: FENC ) Imv Inc (NASDAQ: IMV ) Sienna Biopharmaceuticals Inc (NASDAQ: SNNA ) Vaxart Inc (NASDAQ: VXRT ) Verastem Inc (NASDAQ: VSTM ) See Also: The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs Stock In Focus Motif Says New Iclaprim Data Shows Comparable Efficacy With Standard-of-care MOTIF BIO PLC/S ADR (NASDAQ: MTFB ) presented additional data for iclaprim at the 28th European Congress of Clinical Microbiology and Infectious Diseases, which showed it had comparable efficacy to vancomycin in treating acute bacterial skin and skin structure infection, or ABSSSI, lesions.",AMRX,en,Benzinga
2019-04-01 07:49:42-05:00,Amneal to sell Creo Pharma unit,No summary available.,AMRX,en,Seeking Alpha
2019-03-14 10:00:14-05:00,Daily Insider Ratings Round Up 3/12/19,No summary available.,AMRX,en,Seeking Alpha
2019-03-13 15:27:06-05:00,"Health Care Sector Update for 03/13/2019: AMRX,ACB,ACB.TO,GH,ASND",Top Health Care StocksTop Health Care Stocks JNJ 0 27 JNJ 0 27 PFE 0 52 PFE 0 52 ABT 0 42 ABT 0 42 MRK 0 59 MRK 0 59 AMGN 1 70 AMGN 1 70 Health care stocks still were rising in late Wednesday trading including a 1 0 gain for the NYSE Health Care Index this afternoon Shares,AMRX,en,Nasdaq
2019-03-01 16:46:40-05:00,Amneal Pharma files for mixed shelf offering,No summary available.,AMRX,en,Seeking Alpha
2019-02-28 14:04:06-05:00,"Amneal Pharmaceuticals, Inc (AMRX) CEO Rob Stewart on Q4 2018 Results - Earnings Call Transcript",No summary available.,AMRX,en,Seeking Alpha
2019-02-28 09:25:50-05:00,"Amneal Pharmaceuticals, Inc. 2018 Q4 - Results - Earnings Call Slides",No summary available.,AMRX,en,Seeking Alpha
2019-02-28 07:33:26-05:00,"Amneal Pharmaceuticals beats by $0.06, beats on revenue",No summary available.,AMRX,en,Seeking Alpha
2019-02-27 17:30:27-05:00,Amneal Pharmaceuticals Q4 Earnings Preview,No summary available.,AMRX,en,Seeking Alpha
2019-01-22 08:35:37-05:00,New CFO at Amneal Pharmaceuticals,No summary available.,AMRX,en,Seeking Alpha
2019-01-22 08:35:37-05:00,New CFO at Amneal Pharmaceuticals,No summary available.,AMRX,en,Seeking Alpha
2019-01-14 07:43:19-05:00,FDA OKs Amneal's generic Exelon Patch,No summary available.,AMRX,en,Seeking Alpha
2019-01-14 07:43:19-05:00,FDA OKs Amneal's generic Exelon Patch,No summary available.,AMRX,en,Seeking Alpha
